Correlation Between Ginkgo Bioworks and Biomarin Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Ginkgo Bioworks and Biomarin Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ginkgo Bioworks and Biomarin Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ginkgo Bioworks Holdings and Biomarin Pharmaceutical, you can compare the effects of market volatilities on Ginkgo Bioworks and Biomarin Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ginkgo Bioworks with a short position of Biomarin Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ginkgo Bioworks and Biomarin Pharmaceutical.
Diversification Opportunities for Ginkgo Bioworks and Biomarin Pharmaceutical
0.2 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Ginkgo and Biomarin is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding Ginkgo Bioworks Holdings and Biomarin Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biomarin Pharmaceutical and Ginkgo Bioworks is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ginkgo Bioworks Holdings are associated (or correlated) with Biomarin Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biomarin Pharmaceutical has no effect on the direction of Ginkgo Bioworks i.e., Ginkgo Bioworks and Biomarin Pharmaceutical go up and down completely randomly.
Pair Corralation between Ginkgo Bioworks and Biomarin Pharmaceutical
Considering the 90-day investment horizon Ginkgo Bioworks Holdings is expected to under-perform the Biomarin Pharmaceutical. In addition to that, Ginkgo Bioworks is 2.4 times more volatile than Biomarin Pharmaceutical. It trades about -0.15 of its total potential returns per unit of risk. Biomarin Pharmaceutical is currently generating about -0.05 per unit of volatility. If you would invest 8,678 in Biomarin Pharmaceutical on February 3, 2024 and sell it today you would lose (298.00) from holding Biomarin Pharmaceutical or give up 3.43% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Ginkgo Bioworks Holdings vs. Biomarin Pharmaceutical
Performance |
Timeline |
Ginkgo Bioworks Holdings |
Biomarin Pharmaceutical |
Ginkgo Bioworks and Biomarin Pharmaceutical Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Ginkgo Bioworks and Biomarin Pharmaceutical
The main advantage of trading using opposite Ginkgo Bioworks and Biomarin Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ginkgo Bioworks position performs unexpectedly, Biomarin Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomarin Pharmaceutical will offset losses from the drop in Biomarin Pharmaceutical's long position.Ginkgo Bioworks vs. Pulmatrix | Ginkgo Bioworks vs. Adial Pharmaceuticals | Ginkgo Bioworks vs. Jaguar Animal Health | Ginkgo Bioworks vs. Acasti Pharma |
Biomarin Pharmaceutical vs. Pulmatrix | Biomarin Pharmaceutical vs. Adial Pharmaceuticals | Biomarin Pharmaceutical vs. Jaguar Animal Health | Biomarin Pharmaceutical vs. Acasti Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Complementary Tools
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |